Tech Company Financing Transactions
Myeloid Therapeutics Funding Round
Myeloid Therapeutics, based in Cambridge, raised $73 million in funding from Hatteras Venture Partners, 8VC and Alexandria Venture Investments.
Transaction Overview
Company Name
Announced On
5/18/2023
Transaction Type
Venture Equity
Amount
$73,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds for the continued clinical development of MT-101, its lead cell therapy program in Phase 1/2 for T cell lymphoma, and accelerate the development of MT-302, a first-in-class TROP2-FcA mRNA-LNP product, into a Phase 1/2 study for TROP2-expressing tumors. Additional in vivo programming candidates are also advancing to the clinic.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
300 Technology Sq. 203
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Undisclosed
Website
Email Address
Overview
At Myeloid, we have applied our extensive knowledge of advanced gene and cell therapies to build novel platform technologies and unleash the power of myeloid cells in cancer. Our proprietary ATAK� platform is designed to designed to turn myeloid cells against tumors. These engineered cells find, recognize and penetrate tumors.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Siddhartha Mukherjee
Chief Executive Officer
Daniel Getts
Chief Medical Officer
Michele Gerber
Co-Founder
Yuxiao Wang
Founder
Ronald Vale
VP - Bus. Development
Darren Braccia
Browse more venture capital transactions:
Prev: 5/18/2023: Manifest Cyber venture capital transaction
Next: 5/18/2023: GPR venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We report on all VC transactions involving tech companies. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs